Yang Wenqi, Gauthier Kathryn M, Reddy L Manmohan, Sangras Bhavani, Sharma Kamalesh K, Nithipatikom Kasem, Falck John R, Campbell William B
Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Hypertension. 2005 Apr;45(4):681-6. doi: 10.1161/01.HYP.0000153790.12735.f9. Epub 2005 Feb 7.
5,6-epoxyeicosatrienoic acid (5,6-EET) is a cytochrome P450 epoxygenase metabolite of arachidonic acid that causes vasorelaxation. However, investigations of its role in biological systems have been limited by its chemical instability. We developed a stable agonist of 5,6-EET, 5-(pentadeca-3(Z),6(Z),9(Z)-trienyloxy)pentanoic acid (PTPA), in which the 5,6-epoxide was replaced with a 5-ether. PTPA obviates chemical and enzymatic hydrolysis. In bovine coronary artery rings precontracted with U46619, PTPA (1 nmol/L to 10 micromol/L) induced concentration-dependent relaxations, with maximal relaxation of 86+/-5% and EC50 of 1 micromol/L. The relaxations were inhibited by the cyclooxygenase inhibitor indomethacin (10 micromol/L; max relaxation 43+/-9%); the ATP-sensitive K+ channel inhibitor glybenclamide (10 micromol/L; max relaxation 49+/-6%); and the large conductance calcium-activated K+ channel inhibitor iberiotoxin (100 nmol/L; max relaxation 38+/-6%) and abolished by the combination of iberiotoxin with indomethacin or glybenclamide or increasing extracellular K+ to 20 mmol/L. Whole-cell outward K+ current was increased nearly 6-fold by PTPA (10 micromol/L), which was also blocked by iberiotoxin. Additionally, we synthesized 5-(pentadeca-6(Z),9(Z)-dienyloxy)pentanoic acid and 5-(pentadeca-3(Z),9(Z)-dienyloxy)pentanoic acid (PDPA), PTPA analogs that lack the 8,9 or 11,12 double bonds of arachidonic acid and therefore are not substrates for cyclooxygenase. The PDPAs caused concentration-dependent relaxations (max relaxations 46+/-13% and 52+/-7%, respectively; EC50 1micromol/L), which were not altered by glybenclamide but blocked by iberiotoxin. These studies suggested that PTPA induces relaxation through 2 mechanisms: (1) cyclooxygenase-dependent metabolism to 5-ether-containing prostaglandins that activate ATP-sensitive K+ channels and (2) activation of smooth muscle large conductance calcium-activated K+ channels. PDPAs only activate large conductance calcium-activated K+ channels.
5,6-环氧二十碳三烯酸(5,6-EET)是花生四烯酸的一种细胞色素P450环氧化酶代谢产物,可引起血管舒张。然而,由于其化学不稳定性,对其在生物系统中的作用的研究受到了限制。我们开发了一种5,6-EET的稳定激动剂,5-(十五碳-3(Z),6(Z),9(Z)-三烯氧基)戊酸(PTPA),其中5,6-环氧化物被5-醚取代。PTPA可避免化学和酶促水解。在U46619预收缩的牛冠状动脉环中,PTPA(1 nmol/L至10 μmol/L)诱导浓度依赖性舒张,最大舒张率为86±5%,半数有效浓度(EC50)为1 μmol/L。环氧合酶抑制剂吲哚美辛(10 μmol/L;最大舒张率43±9%)、ATP敏感性钾通道抑制剂格列本脲(10 μmol/L;最大舒张率49±6%)和大电导钙激活钾通道抑制剂iberiotoxin(100 nmol/L;最大舒张率38±6%)可抑制舒张,iberiotoxin与吲哚美辛或格列本脲联合使用或使细胞外钾离子浓度增加至20 mmol/L可消除舒张。PTPA(10 μmol/L)可使全细胞外向钾电流增加近6倍,iberiotoxin也可阻断该电流。此外,我们合成了5-(十五碳-6(Z),9(Z)-二烯氧基)戊酸和5-(十五碳-3(Z),9(Z)-二烯氧基)戊酸(PDPA),这两种PTPA类似物缺乏花生四烯酸的8,9或11,12双键,因此不是环氧合酶的底物。PDPA引起浓度依赖性舒张(最大舒张率分别为46±13%和52±7%;EC50 1 μmol/L),格列本脲对其无影响,但iberiotoxin可阻断。这些研究表明,PTPA通过两种机制诱导舒张:(1)环氧合酶依赖性代谢为含5-醚的前列腺素,激活ATP敏感性钾通道;(2)激活平滑肌大电导钙激活钾通道。PDPA仅激活大电导钙激活钾通道。